Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Legendre

Showing results (41-50 of 456) with videos related to

Pageof 46
Sort By:
Transplantation|May 21, 2024
Liver Transplantation for Polycystic Liver Disease: Definitely not a Cosmetic SurgeryClaire Francoz, Dominique Joly, Christophe Legendre
Drug Safety|May 15, 2004
Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipientsEric Thervet, Frank Martinez, Christophe Legendre
Transplantation|August 7, 2015
Recurrence of Focal and Segmental Glomerulosclerosis After TransplantationGuillaume Canaud, Marianne Delville, Christophe Legendre
The New England Journal of Medicine|January 28, 2011
Treatment of superficial thrombophlebitisAlbane Brodin-Sartorius, Frank Martinez, Christophe Legendre
Transplantation|February 26, 2019
GFR Assessment of Living Kidney Donors CandidatesFrançois Gaillard, Christophe Legendre, Christine A White
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2006
Adverse neuropsychiatric effects of cytomegalovirus prophylaxis with valaciclovir in renal transplant recipientsVincent Das, Marie-Noelle Peraldi, Christophe Legendre
Kidney International Reports|June 25, 2021
Ravulizumab for the Treatment of aHUS in Adults: Improving Quality of LifeChristophe Legendre, Rebecca-Sberro-Soussan, Julien Zuber
The New England Journal of Medicine|May 21, 2015
HIV-positive-to-HIV-positive kidney transplantationGuillaume Canaud, Veronique Avettand-Fenoel, Christophe Legendre
Pharmacogenomics|February 5, 2008
Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an updateDany Anglicheau, Christophe Legendre, Philippe Beaune, et al.
Nephrologie & Therapeutique|September 13, 2006
[Nephrotoxicity of sirolimus: experimental and clinical data]Nicolas Pallet, Eric Thervet, Christophe Legendre, et al.
Pageof 46

Showing results (41-50 of 456) with videos related to

Sort By:
Pageof 46
Transplantation|May 21, 2024
Liver Transplantation for Polycystic Liver Disease: Definitely not a Cosmetic SurgeryClaire Francoz, Dominique Joly, Christophe Legendre
Drug Safety|May 15, 2004
Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipientsEric Thervet, Frank Martinez, Christophe Legendre
Transplantation|August 7, 2015
Recurrence of Focal and Segmental Glomerulosclerosis After TransplantationGuillaume Canaud, Marianne Delville, Christophe Legendre
The New England Journal of Medicine|January 28, 2011
Treatment of superficial thrombophlebitisAlbane Brodin-Sartorius, Frank Martinez, Christophe Legendre
Transplantation|February 26, 2019
GFR Assessment of Living Kidney Donors CandidatesFrançois Gaillard, Christophe Legendre, Christine A White
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2006
Adverse neuropsychiatric effects of cytomegalovirus prophylaxis with valaciclovir in renal transplant recipientsVincent Das, Marie-Noelle Peraldi, Christophe Legendre
Kidney International Reports|June 25, 2021
Ravulizumab for the Treatment of aHUS in Adults: Improving Quality of LifeChristophe Legendre, Rebecca-Sberro-Soussan, Julien Zuber
The New England Journal of Medicine|May 21, 2015
HIV-positive-to-HIV-positive kidney transplantationGuillaume Canaud, Veronique Avettand-Fenoel, Christophe Legendre
Pharmacogenomics|February 5, 2008
Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an updateDany Anglicheau, Christophe Legendre, Philippe Beaune, et al.
Nephrologie & Therapeutique|September 13, 2006
[Nephrotoxicity of sirolimus: experimental and clinical data]Nicolas Pallet, Eric Thervet, Christophe Legendre, et al.
Pageof 46